Meet Climedo Health
Climedo accelerates the introduction of personalised cell therapies by providing doctors with intelligent guidance and analytics throughout clinical trials. Climedo Health received Head Start Funding in 2017 by EIT Health Germany.
Together with the leading university hospitals in Germany, they developed a holistic software solution to efficiently and securely conduct complex treatments. At the same time, they offer real-time feedback and insights to hospitals and connect involved stakeholders.
Benefits include efficient patient onboarding, higher treatment quality and faster time-to-market of new therapies. They received public grants worth 180,000 € and are currently raising their first financing round.
Together with other start-ups and EIT Health staff, Climedo recently presented their company and innovative healthcare solution at the MT Connect in Nuremberg.
The official news item of this event can be found here.